Reactive Blue Prevented Caffeine-Induced Neurotoxicity by an Independent Mechanism from Intracellular Calcium Currents in Cell Culture from Auditory Cortex of Rats

REFERENCES

• Abbracchio M. P., Burnstock G. Purinoceptors: Are there families of P2X and P2Y purinoceptors?. Pharmacology and Therapeutics 1994; 64: 445–475
   PubMed Web of Science ®Google Scholar
• Aranda J. V., Gorman W., Bergsteinson H., Gunn T. Efficacy of caffeine in treatment of apnea in low birth weight infant. Journal of Pediatrics 1977; 90: 467–472
   PubMed Web of Science ®Google Scholar
• Berg M., Bruhn T., Frandsen A., Schousboe A., Diemer N. H. Kainic acid-induced seizures and brain damage in the rat: Role of calcium homeostasis. Journal of Neuroscience Research 1995; 40: 641–646, [CROSSREF]
   PubMedGoogle Scholar
• Cavaliere F., DAmbrosi N., Ciotti M. T., Mancino G., Sancesario G., Bernardi G., Volonte C. Glucose deprivation and mitochondrial dysfunction: Neuroprotection by P2 receptor antagonists. Neurochemistry International 2000; 38: 189–197, [CROSSREF]
   Google Scholar
• Chen J. F., Steyn S., Staal R., Jacobus P. P., Xu K., Cornelis J. V. S., Castagnoli K., Patricia K. S., Castagnoli N., Schwarzschlid M. A. 8-(3-Chlorostyryl) caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A2A Receptor Antagonism. Journal of Biological Chemistry 2002; 27;277((39))36040–36044., [CROSSREF]
   Google Scholar
• D'Ambrosi N., Cavalier F., Merlo D. Antagonists of P2 receptors prevent NGF-dependent neuritogenesis in PC12 cells. Neuropharmacology 2000; 39: 1083–1094; 1787–1795, [CROSSREF]
   PubMedGoogle Scholar
• Dawson V. L., Dawson T. M., Uhl U. R., Snyder S. H. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures. Proceedings of the National Academy of Science 1993; 90: 3256–3259
   PubMed Web of Science ®Google Scholar
• Dall'Igna O. P., Porciuncula L. O., Souza D. O., Cuita R. A., Lara D. R. Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity. Journal of Pharmacology 2003; 38: 1207–1209
   Google Scholar
• Duchen M. R. Roles of mitochondria in health and disease. Diabetes 2004; 53: 96–102
   PubMed Web of Science ®Google Scholar
• Gepdiremen A., Sommez S., Ikbal M., Duzenli S., Tuna S. Response to nimodipine in caffeine-induced neurotoxicity in cerebellar granular cell culture of rat pups. Pharmacological Research 1998; 40: 239–242, [CROSSREF]
   Google Scholar
• Hotchkiss R. S., Karl I. E. Dantrolene ameliorates the metabolic hallmarks of sepsis in rats and improves survival in a mouse model of endotoxemia. Proceedings of the National Academy of Science 1994; 91: 3039–3043
   PubMedGoogle Scholar
• Kang S. H., Lee Y. A., Won S. J., Rhee K. H., Gwag B. J. Caffeine-induced neuronal death in neonatal rat brain and cortical cell cultures. Neuroreport 2002; 28((15))1945–1950
   Google Scholar
• Klenerman L., Lowe N. M., Miller L., Fryer P. R., Green C. J., Jackson M. J. Dantrolene sodium protects against experimental ischemia and reperfusion damage to skeletal muscle. Acta Orthopaedica Scandinavia 1995; 66: 352–358
   PubMed Web of Science ®Google Scholar
• Li C. Y., Chou T. C., Wu C. C., Wong C. S., Ho S. T., Yen M. H., Ding Y. A. Dantrolene inhibits nitric oxide synthase in rat alveolar macrophages treated with lipopolysaccharide and interferon-g. Canadian Journal of Anaesth 1998; 45: 246–252
   PubMedGoogle Scholar
• Lindskog M., Svenningsson P., Pozzi L., Kim Y., Fienberg A. A., Bibb J. A., Fredholm B. B., Nairn A. C., Greengard P., Fisone G. Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 2002; 418: 774–778, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mody I., MacDonald J. F. NMDA receptor-dependent excitotoxicity: The role of intracellular Ca21 release. Trends in Pharmacological Sciences 1995; 16: 356–359, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nakazawa K., Inoue K., Ito K., Koizumi S., Inoue K. Inhibition by suramin and reactive blue 2 of GABA and glutamate receptor channels in rat hippocampal neurons. Naunyn Schmiedebergs Arch Pharmacology 1995; 351: 202–208
   PubMedGoogle Scholar
• Peoples R. W., Li C. Inhibition of NMDA-gated ion channels by the P2 purinoceptor antagonists suramin and reactive blue 2 in mouse hippocampal neurons. British Journal of Pharmacology 1998; 124: 400–408
   PubMedGoogle Scholar
• Queiroz G., Talaia C., Goncalves J. ATP modulates noradrenaline release by activation of inhibitory P2Y receptors and facilitatory P2X receptors in the rat vas deferens. Journal of Pharmacol Experimental Therapy 2003; 307: 809–815, [CROSSREF]
   PubMedGoogle Scholar
• Schlegel R., Paradee A. B. Caffeine induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. Science 1986; 232: 1264–1266
   PubMed Web of Science ®Google Scholar
• Simpson P. B., Challiss R. A. J., Nahorski S. R. Neuronal Ca2+ stores: Activation and function. Trends in Neuroscience 1995; 18: 299–306, [CROSSREF]
   PubMedGoogle Scholar
• Solinas M., Ferre S., You Z. B., Karcz-Kubicha M., Popoli P., Goldberg S. R. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. Journal of Neuroscience 2002; 22: 6321–6324
   PubMed Web of Science ®Google Scholar
• Stone T. W. Neuropharmacology, et al. Printed by Bell & Bain Limited, New York 1995
   Google Scholar
• Trendelenburg A. U., Bultmann R. P2 receptor-mediated inhibition of dopamine release in rat neostriatum. Neuroscience 2000; 96: 249–252, [CROSSREF]
   PubMedGoogle Scholar
• Volonte C., Merlo D. Selected P2 receptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurones. Journal of Neuroscience Research 1996; 45: 183–193, [CROSSREF]
   PubMedGoogle Scholar
• Volonte C., Ciotti M. T., D'Ambrosi N., Lockhart B., Spedding M. Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones. Neuropharmacology 1999; 38: 1335–1342, [CROSSREF]
   PubMedGoogle Scholar
• Wei H., Perry D. C. Dantrolene is cytoprotective in two models of neuronal cell death. Journal of Neurochemistry 1996; 67: 2390–2398
   PubMedGoogle Scholar
• Wisor J. P., Nishino S., Sora I., Uhl G. H., Mignot E., Edgar D. M. Dopaminergic role in stimulant-induced wakefulness. Journal of Neuroscience 2001; 21: 1787–1794
   PubMed Web of Science ®Google Scholar
• Xu J., Wojcik W. J. Gamma aminobutyric acid B receptor mediated inhibition of adenylate cyclase in cultured cerebellar granule cells: Blockade by islet activating protein. Journal of Pharmacology 1986; 239: 568–573
   Google Scholar
• Yoon K. W., Mitchell H. I., Broder L. D., Broker R. W., Delilse R. K. Trauma-induced neurotoxicity in rat hippocampal neurons. Stroke 1996; 27: 122–126
   PubMedGoogle Scholar